Nanox has achieved a significant milestone by obtaining the EU MDR CE mark for its HealthOST software, an innovative tool designed to enhance spine health assessments through AI-powered analysis.
HealthOST Enhances Early Detection of Osteoporosis
The HealthOST software, developed by Nanox.AI Ltd, leverages artificial intelligence to evaluate vertebral height loss and bone mineral density using routine CT scans. This advancement allows for the consistent and objective assessment of musculoskeletal diseases, such as osteoporosis, which often remain undiagnosed until severe fractures occur.
Integration and Cost-Effectiveness Drive Adoption
HealthOST seamlessly integrates with existing Picture Archiving and Communication Systems (PACS), enabling healthcare providers to implement the software without the need for additional imaging or increased patient time. This integration not only streamlines workflows but also offers a cost-effective screening solution, addressing the critical gap in early osteoporosis detection.
Key inferences from Nanox’s achievement include:
– The CE mark certification allows HealthOST to be marketed across Europe, expanding its reach and impact.
– Early detection capabilities of HealthOST can potentially reduce the €56 billion annual cost associated with osteoporosis-related fractures in Europe.
– Integration with routine CT scans eliminates the need for extra procedures, promoting broader adoption in healthcare settings.
HealthOST has demonstrated effectiveness in clinical settings, notably in the ADOPT study conducted across four UK NHS trusts. The study revealed that HealthOST identified over 3,450 new patients with vertebral compression fractures, highlighting its potential to uncover cases that traditional methods might miss.
The successful integration of HealthOST into clinical pathways at institutions like the University of Oxford underscores its practicality and benefits. By enabling earlier identification of high-risk patients, HealthOST supports preventive care measures, which can lead to improved patient outcomes and reduced strain on healthcare systems.
As Europe faces a growing population at risk of osteoporosis, Nanox’s HealthOST offers a timely solution. Healthcare facilities looking to enhance their diagnostic capabilities and implement cost-effective screening tools can explore HealthOST through Nanox’s official channels.
Nanox’s advancement with HealthOST exemplifies the pivotal role of AI in modern healthcare. By addressing the critical need for early osteoporosis detection, Nanox not only contributes to better health outcomes but also supports the sustainability of healthcare systems facing increasing demand due to an aging population.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
